ReviewDiagnostics (Basel, Switzerland)2026
Advances in Artificial Intelligence for Gastrointestinal Endoscopy: 2026 Update.
Review in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Artificial intelligence (AI) is transforming gastrointestinal (GI) endoscopy into a more standardized, data-driven, and workflow-integrated field. Advances in computer-assisted detection (CADe), diagnosis (CADx), quality assessment (CAQ), natural language processing (NLP), and multimodal deep learning have expanded AI applications across colonoscopy, upper endoscopy, endoscopic ultrasound (EUS), ERCP, cholangioscopy, and capsule endoscopy. These systems have demonstrated improvements in lesion detection, procedural quality assessment, workflow efficiency, and diagnostic support. However, current evidence remains largely focused on surrogate outcomes rather than patient-centered clinical benefits, while challenges related to generalizability, explainability, regulatory oversight, automation bias, and workflow integration continue to limit widespread adoption. Future progress will depend on prospective real-world validation, diverse datasets, explainable AI frameworks, and careful integration of human-AI interaction into clinical practice. Overall, AI is evolving from a supportive adjunct into an increasingly integrated component of gastrointestinal endoscopy with the potential to improve procedural quality, diagnostic consistency, and clinical efficiency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.